FOXP3 and COVID-19: Given that hypoxia can induce the activation of hypoxia-inducible factor-1α (HIF-1α) within the pulmonary microenvironment, resulting in subsequent proteasome-mediated degradation of FOXP3 and thereby impeding Tregs differentiation, oxygen inhalation emerges as a pivotal therapeutic intervention for severe COVID-19 (221).